Pharmaceutical Company Biogen to Pay $900M False Claims Act Settlement
- Monday, Boston pharmaceutical company Biogen agreed to pay $900 million to settle a case where it was accused of offering illegal programs that induced physicians to prescribe the drugs Avonex, Tysabri, and Tecfidra. Whistleblower and former Biogen employee Michael Bawduniak filed and litigated the case on behalf of the federal...
